glutathione mutations in sclc patients Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation | Cancer & Metabolism Integrated methylome analysis identifies an

Integrated methylome analysis identifies an epigenetically silenced tumor suppressor RASA4 in small cell lung cancer Communications Biology Frontiers Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death Role of the Glutathione Metabolic Pathway in Lung Cancer Treatment and Prognosis: A Review Journal of Clinical Oncology The role of ERBB4 mutations in the prognosis of advanced non small cell lung cancer treated with immune checkpoint inhibitors Molecular Medicine Springer Nature Link Increased antioxidative defense and reduced advanced glycation end product formation by metabolic adaptation in non small cell lung cancer patients Nature Communications

SKU: 96444229470 · From crisbcreativa.com